Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS) is a healthcare company (biotechnology) based in the United States. The share price is $11.31, up 12.76% on the day, which values the company at $221.95M. Price as of 18 Nov 2026, 12:04 UTC, from Yahoo Finance.

Key facts

Share price
$11.31+12.76% today
Market value
$221.95M
Funk Score
89/100
Against its own history
Well below its usual priceusual price $234.11
200-week average
$30.3963% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Keros Therapeutics, Inc. in more detail

KROS trades at -2.0× next year's expected earnings, 5.4× sales. Measured against its own history, the price is 95% below what its usual multiples would imply ($234.11) — well below its usual price. It sits 63% below its 200-week average of $30.39.

Its Funk Score is 89 out of 100 (financial strength 8.6, profitability 8.1, value 10.0, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Share count keeps rising.

Keros Therapeutics, Inc. (KROS): questions and answers

What is Keros Therapeutics, Inc.'s market cap?

Keros Therapeutics, Inc. is valued at $221.95M at a share price of $11.31.

Is KROS overvalued or undervalued?

Against its own history, KROS is well below its usual price: the price is 95% below the $234.11 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is KROS above its 200-week moving average?

No. KROS is 62.8% below its 200-week average of $30.39. Long-term investors watch that line because strong companies rarely trade below it for long.

Does KROS pay a dividend?

Keros Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/KROS

Underlying data: Yahoo Finance; company filings with the SEC.